View all reports
Cullinan Oncology, Inc. (CGEM) stock forecast and price target
Find the latest Cullinan Oncology, Inc. CGEM analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Date Range
investment rating
report type
sector
industry
provider
CGEMCullinan Therapeutics, Inc.25.30 +6.05 (+31.43%)
At close: 08:00PM
Recommendation Rating
1.5
Analyst Price Targets (6)
Current 25.30
Average 28.00
Low 19.00
High 36.00
Related Research Reports1-3 of 3 results
| Report Name | Symbols | Sector | Provider | Date | |
|---|---|---|---|---|---|
| ACLX,EVA,COST,CRWD,CGEM,LLY,EYEN,OII | Energy,Basic Materials,Technology,Healthcare,Consumer Defensive | Argus | Jun 24, 2022 | Upgrade to begin downloading full reports | |
| LILA,RPRX,CGEM,ABCL,TYL,AMR,PRGS,TOST,ICUI,AHCO | Communication Services,Basic Materials,Technology,Healthcare | Argus | May 17, 2022 | Upgrade to begin downloading full reports | |
| CALM,FLXS,CGEM,MBI,LLY,ALRM,CPNG,QRHC,XAIR | Financial Services,Technology,Healthcare,Consumer Defensive,Industrials,Consumer Cyclical | Argus | Apr 07, 2022 | Upgrade to begin downloading full reports |